925 results on '"Harrison, Christine J."'
Search Results
2. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
3. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
4. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia
5. A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study
6. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial
7. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia
8. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
9. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group
10. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21
11. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia
12. Pelops: A dedicated caller for DUX4 rearrangements from whole-genome sequencing data
13. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
14. Genetic characterization and therapeutic targeting of MYC‐rearranged T cell acute lymphoblastic leukaemia
15. hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia
16. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study
17. Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
18. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
19. HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
20. Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
21. PCR amplicons identify widespread copy number variation in human centromeric arrays and instability in cancer
22. Genetic alterations in lymphoblastic leukaemia / lymphoma – a practical guide to WHO HAEM5
23. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials
24. Cytogenetics and Molecular Genetics
25. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
26. Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
27. The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
28. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia
29. Prevention of childhood leukaemia by lifestyle changes
30. HGNC nomenclature for fusion genes
31. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group
32. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia
33. Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia
34. Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
35. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia
36. Supplementary Table 4 from Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
37. Supplementary Table 3 from Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
38. Supplementary Table 1 from Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
39. Supplementary Table 2 from Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
40. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia
41. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia
42. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
43. Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease
44. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial
45. Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial
46. Treatment Outcomes of Childhood Picalm:MLLT10+ Acute Leukemias: An International Retrospective Study
47. Whole Genome Sequencing for Detection of Prognostically Relevant Genetic Abnormalities in Paediatric Acute Myeloid Leukaemia
48. Diagnostic Utility of Whole Genome Sequencing in Adults with B-Other Acute Lymphoblastic Leukaemia
49. 72. Variant curation of BCR::ABL1-like B-lymphoblastic leukemia/lymphoma through expert panel consensus
50. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.